Point-of-Need Sequencing for Clinical Diagnosis
pitch_v1_importSee something off about this company?
Today, genetic sequencing is clinically valuable but operationally inaccessible for most labs. The bottleneck is not the sequencer itself, but the up-front workflow: sample prep, library prep, and cleanup. These steps are manual, slow, and difficult to scale for diagnostic testing throughputs. As a result, sequencing remains concentrated in specialized, low-scale centers instead of reaching the much broader clinical markets that need it.